Pei-Jer Chen, MD, PhD
National Taiwan University Hospital
3
2
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Marc G Ghany, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Cheng-Chao Liang, MD
Far Eastern Memorial Hospital
Shared therapeutic areas:
Worked with same sponsors:
Chun-Jen Liu, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sheng-Shun Yang, MD
Taichung Veterans General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jia-Horng Kao, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ding-Shinn Chen, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Chen-Hua Liu, MD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Ming-Yang Lai, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
PI-88 in Hepatocellular Carcinoma After Hepatectomy
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
All 3 trials loaded